ace-i angioedema and ffp
DESCRIPTION
ACE-I Angioedema and FFP. Tom Grosheider Evidence in the ED April 10, 2013. Background. Angiotensin II AKA kinase II Accumulation of kinins thought responsible for angioedema through opaque mechanism Cough is most common side effect (up to 25% of patients) - PowerPoint PPT PresentationTRANSCRIPT
ACE-I Angioedema ACE-I Angioedema and FFPand FFP
Tom GrosheiderTom Grosheider
Evidence in the EDEvidence in the ED
April 10, 2013April 10, 2013
BackgroundBackground
Angiotensin II AKA kinase II Angiotensin II AKA kinase II Accumulation of kinins thought Accumulation of kinins thought
responsible for angioedema through responsible for angioedema through opaque mechanismopaque mechanism
Cough is most common side effect Cough is most common side effect (up to 25% of patients)(up to 25% of patients)
Angioedema occurs in 0.1%-0.7% of Angioedema occurs in 0.1%-0.7% of patientspatients
Conventional TreatmentConventional Treatment
Diphenhydramine, steroids, H1-Diphenhydramine, steroids, H1-blocker, and epinepherine if severeblocker, and epinepherine if severe
Airway monitoringAirway monitoring Intubation Intubation Discontinue treatment and it usually Discontinue treatment and it usually
gets better in 24-48 hoursgets better in 24-48 hours
FFPFFP
Adopted from literature supporting Adopted from literature supporting its use in hereditary angioedemaits use in hereditary angioedema
In ACE-I AE, thought to be useful In ACE-I AE, thought to be useful because it contains kinin II, which because it contains kinin II, which catalyzes the breakdown of catalyzes the breakdown of bradykininbradykinin
Scant literatureScant literature
Article 1Article 1
Hassan, WH., Kalantari, H., Parraga, M., Hassan, WH., Kalantari, H., Parraga, M., Chirugi, R., Meletiche, C., Chan, C., Chirugi, R., Meletiche, C., Chan, C., Ciarlo., J, Gazi, F., Lobaito, C., Tadayon, Ciarlo., J, Gazi, F., Lobaito, C., Tadayon, S., Yemane, S., Velez, C., “Fresh Frozen S., Yemane, S., Velez, C., “Fresh Frozen Plasma for Progressive and Refractory Plasma for Progressive and Refractory Angiotensin-Converting Enzyme Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema,” The Inhibitor-Induced Angioedema,” The Journal of Emergency Medicine, Vol. 44, Journal of Emergency Medicine, Vol. 44, No. 4, pp 764-772, 2013. No. 4, pp 764-772, 2013.
Article 1Article 1
Case series of 7 patients treated for Case series of 7 patients treated for presumed ACE-I angioedemapresumed ACE-I angioedema
Subset from a larger retrospective Subset from a larger retrospective chart review delineating rate, causes, chart review delineating rate, causes, and ethnic differences from 2003-and ethnic differences from 2003-20122012
Identified 7 patients with severe, Identified 7 patients with severe, refractory ACE-I AE who improved refractory ACE-I AE who improved temporally with administration of FFP temporally with administration of FFP
Article 1Article 1 Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Case 7
Age in years 49 64 58 62 51 73 45
Gender Female Male Male Male Female Male Male
Ethnicity AA AA Hispanic Hispanic AA AA AA
Dose and type of ACEI 40 mg lisinopril 40 mg lisinopril 30 mg lisinopril Enalapril Lisinopril Lisinopril
10 mg enalapril
Duration of use 1 year 1 year 3 years Unknown Unknown Unknown Unknown
ComorbiditiesDM<comma>
Asthma
Hepatitis C<comma> HIV
FFP units 2U 3U 2U 2U 2U 2U 1U
C1 esterase Normal Normal Normal Normal Normal
C1 quantitative Normal Normal
C2 Normal Normal Normal
C3 Normal Normal
C4 Normal Normal Normal
Angioedema course Progressive Progressive Progressive Progressive Progressive Progressive Progressive
Disposition ICU ICU ICU ICU ICU ICU ICU
LimitationsLimitations
Case reportsCase reports No evidence of causalityNo evidence of causality Small sample sizeSmall sample size Not everyone had a workup for HAENot everyone had a workup for HAE
Article 2Article 2
Bolton, MR., Dooley-Bolton, MR., Dooley-Hash, S., Hash, S., “Angiotensin-“Angiotensin-Converting Enzyme Converting Enzyme Inhibitor Inhibitor Angioedema,” Angioedema,” Journal of Journal of Emergency Emergency Medicine, Vol 43, Medicine, Vol 43, No. 4, pp. e261-No. 4, pp. e261-262, 2012.262, 2012.
Article 2Article 2
Single case report of a 76 y/o Single case report of a 76 y/o gentleman with facial and tongue gentleman with facial and tongue swellingswelling
Refractory to steroids and benadrylRefractory to steroids and benadryl Got better with 2u FFPGot better with 2u FFP Also, he had had a minor procedure Also, he had had a minor procedure
requiring LMA earlier in the day and requiring LMA earlier in the day and never had an HAE work-upnever had an HAE work-up
Article 3Article 3
Warrier, M., Copilevitz, C., Dykewicz., Warrier, M., Copilevitz, C., Dykewicz., “Fresh Frozen Plasma in the “Fresh Frozen Plasma in the Treatment of Resistant Angiotensin-Treatment of Resistant Angiotensin-converting Enzyme Inhibitor converting Enzyme Inhibitor Angioedema,” Annals of Allergy and Angioedema,” Annals of Allergy and Innunology, 9: 573-575, 2004.Innunology, 9: 573-575, 2004.
Article 3Article 3
43 y/o woman recently started on 43 y/o woman recently started on ramipril with AEramipril with AE
Resistant to steroids, benadryl, and Resistant to steroids, benadryl, and sub-q epi x2sub-q epi x2
Improved with 2u FFPImproved with 2u FFP
HUPismHUPism
ACE-I AE can be severe and life-ACE-I AE can be severe and life-threateningthreatening
FFP is not without risksFFP is not without risks FFP may be considered in severe, FFP may be considered in severe,
refractory cases of ACE-I AE, but the refractory cases of ACE-I AE, but the evidence is quite limitedevidence is quite limited